- Home
- Companies
- Irrimax Corporation
- Articles
- Executive Summary Biofilm Testing of ...
Executive Summary Biofilm Testing of Irrisept Antimicrobial Wound Lavage in an In Vitro Model - Case Study
Courtesy of Irrimax Corporation
Objective
An in vitro test was carried out to assess the ability of the Irrisept Antimicrobial Wound Lavage (Irrisept) device to disrupt and reduce clinically relevant biofilms. The testing approach used methods adapted from ASTM E2871-19, “Standard Test Method for Determining Disinfection Efficacy Against Biofilm Grown in the CDC Biofilm Reactor Using the Single Tube Method.”
-
Most popular related searches
Customer comments
No comments were found for Executive Summary Biofilm Testing of Irrisept Antimicrobial Wound Lavage in an In Vitro Model - Case Study. Be the first to comment!